DCZ-0415 | m-entrepreneurship.com

Product Name :
DCZ-0415

Search keywords :
DCZ0415

drugId :
null

Target Vo:
Pachytene checkpoint protein 2 homolog

Target Vo Short Name :
TRIP13

Moa_Name:
Pachytene checkpoint protein 2 homolog inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai East Hospital,Tongji University School Of Medicine

Active Company_Name :
Shanghai East Hospital,Tongji University School Of Medicine

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
xCT Antibody (YA006)
Phospho-AKT1 (Ser473) Antibody
Integrin alpha V Antibody: Integrin alpha V Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 116 kDa, targeting to Integrin alpha V. It can be used for WB,ICC,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts